|
Application for quotation of securities - ADR
|
28 June 2023 at 4:55pm
|
|
Change of Auditor
|
27 June 2023 at 10:10am
|
|
Notification of cessation of securities - ADR
|
11 May 2023 at 2:10pm
|
|
Change of Company Secretary
|
4 May 2023 at 9:40am
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
27 April 2023 at 10:20am
|
|
US FDA clearance of Adherium's Hailie for Teva inhalers
|
23 March 2023 at 12:30pm
|
|
Ceasing to be a substantial holder
|
27 February 2023 at 8:40pm
|
|
Half Yearly Report and Accounts
|
27 February 2023 at 2:15pm
|
|
Change in substantial holding
|
21 February 2023 at 8:10am
|
|
Becoming a substantial holder
|
20 February 2023 at 6:40pm
|
|
Ceasing to be a substantial holder
|
16 February 2023 at 7:30pm
|
|
Adherium Exhibiting at AAAAI 2023 Annual Meeting
|
13 February 2023 at 10:10am
|
|
Becoming a substantial holder
|
2 February 2023 at 8:40am
|
|
Change in substantial holding
|
1 February 2023 at 8:45pm
|
|
Adherium launches new Interactive Investor Hub
|
1 February 2023 at 8:55am
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 January 2023 at 10:50am
|
|
Notification regarding unquoted securities - ADR
|
25 January 2023 at 12:30pm
|
|
Application for quotation of securities - ADR
|
25 January 2023 at 12:30pm
|
|
Ellipta Production and Market Release
|
20 January 2023 at 9:05am
|
|
ADR TGA Approval for Next Generation Sensors
|
20 January 2023 at 9:00am
|
|
Adherium Awarded UK NHS SBRI Healthcare Monitoring Project
|
18 January 2023 at 2:20pm
|
|
Adherium to present at J.P. Morgan Healthcare Conference
|
10 January 2023 at 2:40pm
|
|
Ceasing to be a substantial holder
|
14 December 2022 at 7:10pm
|
|
Change in substantial holding (Trudell Medical)
|
13 December 2022 at 3:05pm
|
|
Change of Director's Interest Notice (G Baran)
|
13 December 2022 at 3:00pm
|
|
Cleansing notice under s708A of the Corporations Act
|
13 December 2022 at 2:50pm
|
|
Notification regarding unquoted securities - ADR
|
12 December 2022 at 10:40am
|
|
Application for quotation of securities - ADR
|
12 December 2022 at 10:25am
|
|
Notification regarding unquoted securities - ADR
|
12 December 2022 at 10:20am
|
|
Application for quotation of securities - ADR
|
12 December 2022 at 10:20am
|
|
Adherium Share Purchase Plan Offer Results
|
9 December 2022 at 10:25am
|
|
Application for quotation of securities - ADR
|
8 December 2022 at 10:15am
|
|
Adherium receives $1.3m Australian R&D Tax Incentive
|
2 December 2022 at 10:15am
|
|
Final Director's Interest Notice
|
2 December 2022 at 8:45am
|
|
Results of Meeting and Director Update
|
30 November 2022 at 4:00pm
|
|
CEO's Address to Shareholders at AGM
|
30 November 2022 at 3:30pm
|
|
US FDA clearance of Adherium's Hailie for GSK inhalers
|
28 November 2022 at 8:50am
|
|
Adherium exhibiting at 2022 BTS Winter Meeting
|
24 November 2022 at 12:40pm
|
|
Adherium SPP and Shortfall Offers Prospectus
|
17 November 2022 at 2:30pm
|
|
Update - Proposed issue of securities - ADR
|
16 November 2022 at 2:15pm
|
|
Update - Proposed issue of securities - ADR
|
16 November 2022 at 2:10pm
|
|
Adherium Exhibiting at ACAAI 2022
|
11 November 2022 at 8:45am
|
|
Becoming a substantial holder
|
7 November 2022 at 8:40am
|
|
Change of Director's Interest Notice (L Panaccio)
|
4 November 2022 at 9:25am
|
|
Change of Director's Interest Notice (G Baran)
|
4 November 2022 at 9:25am
|
|
Change in substantial holding
|
3 November 2022 at 9:55am
|
|
Change in substantial holding
|
3 November 2022 at 9:45am
|
|
Disclosure of Long Equity Derivative Positions
|
2 November 2022 at 2:00pm
|
|
Change in substantial holding
|
2 November 2022 at 8:35am
|
|
Notice of Annual General Meeting/Proxy Form
|
1 November 2022 at 4:50pm
|
Adherium